These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 22047086

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. A prospective cohort study comparing the effect of single-dose 2 g metronidazole on Trichomonas vaginalis infection in HIV-seropositive versus HIV-seronegative women.
    Balkus JE, Richardson BA, Mochache V, Chohan V, Chan JD, Masese L, Shafi J, Marrazzo J, Farquhar C, McClelland RS.
    Sex Transm Dis; 2013 Jun; 40(6):499-505. PubMed ID: 23677023
    [Abstract] [Full Text] [Related]

  • 3. Effect of trichomoniasis therapy on genital HIV viral burden among African women.
    Anderson BL, Firnhaber C, Liu T, Swarts A, Siminya M, Ingersoll J, Caliendo AM, Cu-Uvin S.
    Sex Transm Dis; 2012 Aug; 39(8):638-42. PubMed ID: 22797689
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Trichomonas vaginalis treatment reduces vaginal HIV-1 shedding.
    Kissinger P, Amedee A, Clark RA, Dumestre J, Theall KP, Myers L, Hagensee ME, Farley TA, Martin DH.
    Sex Transm Dis; 2009 Jan; 36(1):11-6. PubMed ID: 19008776
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Hormonal contraception, vitamin A deficiency, and other risk factors for shedding of HIV-1 infected cells from the cervix and vagina.
    Mostad SB, Overbaugh J, DeVange DM, Welch MJ, Chohan B, Mandaliya K, Nyange P, Martin HL, Ndinya-Achola J, Bwayo JJ, Kreiss JK.
    Lancet; 1997 Sep 27; 350(9082):922-7. PubMed ID: 9314871
    [Abstract] [Full Text] [Related]

  • 9. The effect of treatment of vaginal infections on shedding of human immunodeficiency virus type 1.
    Wang CC, McClelland RS, Reilly M, Overbaugh J, Emery SR, Mandaliya K, Chohan B, Ndinya-Achola J, Bwayo J, Kreiss JK.
    J Infect Dis; 2001 Apr 01; 183(7):1017-22. PubMed ID: 11237825
    [Abstract] [Full Text] [Related]

  • 10. Improvement of vaginal health for Kenyan women at risk for acquisition of human immunodeficiency virus type 1: results of a randomized trial.
    McClelland RS, Richardson BA, Hassan WM, Chohan V, Lavreys L, Mandaliya K, Kiarie J, Jaoko W, Ndinya-Achola JO, Baeten JM, Kurth AE, Holmes KK.
    J Infect Dis; 2008 May 15; 197(10):1361-8. PubMed ID: 18444793
    [Abstract] [Full Text] [Related]

  • 11. Trichomonas vaginalis prevalence, incidence, risk factors and antibiotic-resistance in an adolescent population.
    Krashin JW, Koumans EH, Bradshaw-Sydnor AC, Braxton JR, Evan Secor W, Sawyer MK, Markowitz LE.
    Sex Transm Dis; 2010 Jul 15; 37(7):440-4. PubMed ID: 20351623
    [Abstract] [Full Text] [Related]

  • 12. Single-dose versus 7-day-dose metronidazole for the treatment of trichomoniasis in women: an open-label, randomised controlled trial.
    Kissinger P, Muzny CA, Mena LA, Lillis RA, Schwebke JR, Beauchamps L, Taylor SN, Schmidt N, Myers L, Augostini P, Secor WE, Bradic M, Carlton JM, Martin DH.
    Lancet Infect Dis; 2018 Nov 15; 18(11):1251-1259. PubMed ID: 30297322
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Cervicovaginal HIV-1 shedding in women taking antiretroviral therapy in Burkina Faso: a longitudinal study.
    Low AJ, Konate I, Nagot N, Weiss HA, Kania D, Vickerman P, Segondy M, Mabey D, Pillay D, Meda N, van de Perre P, Mayaud P, Yerelon Study Group.
    J Acquir Immune Defic Syndr; 2014 Feb 01; 65(2):237-45. PubMed ID: 24226060
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Trichomonas vaginalis infection and the diagnostic significance of detection tests among Ghanaian outpatients.
    Asmah RH, Agyeman RO, Obeng-Nkrumah N, Blankson H, Awuah-Mensah G, Cham M, Asare L, Ayeh-Kumi PF.
    BMC Womens Health; 2018 Dec 27; 18(1):206. PubMed ID: 30591043
    [Abstract] [Full Text] [Related]

  • 17. A cross-sectional analysis of Trichomonas vaginalis infection among heterosexual HIV-1 serodiscordant African couples.
    Bochner AF, Baeten JM, Rustagi AS, Nakku-Joloba E, Lingappa JR, Mugo NR, Bukusi EA, Kapiga S, Delany-Moretlwe S, Celum C, Barnabas RV, Partners in Prevention HSV/HIV Transmission Study and Partners PrEP Study Teams.
    Sex Transm Infect; 2017 Nov 27; 93(7):520-529. PubMed ID: 28377421
    [Abstract] [Full Text] [Related]

  • 18. Effect of acquisition and treatment of cervical infections on HIV-1 shedding in women on antiretroviral therapy.
    Gitau RW, Graham SM, Masese LN, Overbaugh J, Chohan V, Peshu N, Richardson BA, Jaoko W, Ndinya-Achola JO, McClelland RS.
    AIDS; 2010 Nov 13; 24(17):2733-7. PubMed ID: 20871388
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The presence of dsRNA virus in Trichomonas vaginalis isolates from symptomatic and asymptomatic Indian women and its correlation with in vitro metronidazole sensitivity.
    Malla N, Kaul P, Sehgal R, Gupta I.
    Indian J Med Microbiol; 2011 Nov 13; 29(2):152-7. PubMed ID: 21654110
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.